Stockscreener 앱 받기
3.92
6.23%
0.23
전일 마감가:
$3.69
열려 있는:
$3.74
하루 거래량:
1.49M
Relative Volume:
1.10
시가총액:
$568.49M
수익:
$288.95M
순이익/손실:
$-119.03M
주가수익비율:
-4.3531
EPS:
-0.9005
순현금흐름:
$60.67M
1주 성능:
-0.25%
1개월 성능:
+9.19%
6개월 성능:
+55.56%
1년 성능:
-14.22%
1일 변동 폭
$3.73
$4.00
1주일 범위
$3.645
$4.105
52주 변동 폭
$1.665
$6.05
마라바이 라이프 Stock (MRVI) Company Profile
명칭
Maravai Lifesciences Holdings Inc
전화
(858) 546-0004
주소
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
MRVI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
3.92 | 535.13M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
마라바이 라이프 Stock (MRVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | 개시 | Guggenheim | Neutral |
| 2024-12-05 | 다운그레이드 | Goldman | Neutral → Sell |
| 2024-11-14 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-08 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-08-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | 개시 | Craig Hallum | Buy |
| 2023-12-12 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-08-08 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-01-05 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-11-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2020-12-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | 개시 | BofA Securities | Buy |
| 2020-12-15 | 개시 | Credit Suisse | Outperform |
| 2020-12-15 | 개시 | Goldman | Buy |
| 2020-12-15 | 개시 | Jefferies | Buy |
| 2020-12-15 | 개시 | Robert W. Baird | Outperform |
| 2020-12-15 | 개시 | Stifel | Buy |
| 2020-12-15 | 개시 | William Blair | Outperform |
| 2020-12-14 | 개시 | UBS | Buy |
모두보기
마라바이 라이프 주식(MRVI)의 최신 뉴스
Maravai LifeSciences (NASDAQ:MRVI) Shares Down 5.8%Should You Sell? - MarketBeat
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Beha - GuruFocus
Maravai LifeSciences (NASDAQ:MRVI) & Capricor Therapeutics (NASDAQ:CAPR) Critical Review - Defense World
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Treasury Yields: Is Maravai LifeSciences Holdings Inc stock oversold or undervaluedRisk Management & Free Growth Oriented Trading Recommendations - Bộ Nội Vụ
Maravai LifeSciences Earnings Call: Mixed Signals - MSN
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q3 Loss, Misses Revenue Estimates - MSN
Can Maravai LifeSciences Holdings Inc. stock withstand economic slowdownWatch List & AI Optimized Trading Strategy Guides - ulpravda.ru
Maravai LifeSciences Holdings (MRVI) Stock Analysis: An Investor’s Guide to Navigating the Biotech Sector - DirectorsTalk Interviews
Why Maravai LifeSciences Holdings Inc. stock is in analyst buy zoneJuly 2025 Sentiment & Weekly High Conviction Ideas - Улправда
How MACOM Technology Solutions Holdings Inc. stock trades during market volatilityJuly 2025 Patterns & AI Enhanced Market Trend Forecasts - ulpravda.ru
Is Maravai LifeSciences Holdings Inc. stock oversold or undervaluedTrade Entry Report & Verified Momentum Stock Ideas - Улправда
Investors Purchase High Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - MarketBeat
Is Maravai LifeSciences Holdings Inc. stock resilient to inflationMACD Trading Signals & Rapid Portfolio Investment - Улправда
How Maravai LifeSciences Holdings Inc. (MAR) stock gains from tech spendingStock Watchlist Updates & Free Trading Psychology Coaching - Улправда
How buybacks impact Maravai LifeSciences Holdings Inc. stock valueEarnings Revision Updates & Identify Winning Stocks - Улправда
Volume Summary: Can Maravai LifeSciences Holdings Inc stock withstand economic slowdownJuly 2025 Analyst Calls & Consistent Profit Alerts - Bộ Nội Vụ
A US$75m Market Cap Boost Pleasing ToMaravai LifeSciences Holdings Insiders - simplywall.st
Maravai LifeSciences (NASDAQ:MRVI) Nasdaq Index Life Sciences Inputs - Kalkine Media
Net current asset value per share of Maravai Lifesciences Holdings, Inc. Class A – SWB:MAR - TradingView — Track All Markets
Maravai LifeSciences (NASDAQ:MRVI) Trading Up 11.3%Time to Buy? - MarketBeat
Ideas Watch: Is Maravai LifeSciences Holdings Inc. stock resilient to inflationMarket Volume Summary & Weekly Stock Performance Updates - Bộ Nội Vụ
Maravai LifeSciences Holdings Inc Stock Analysis and ForecastRSI Overbought/Oversold & Free Superior Trading Gains - earlytimes.in
Critical Analysis: Maravai LifeSciences (NASDAQ:MRVI) versus TerrAscend (OTCMKTS:TSNDF) - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Investors Buy Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Shares Down 4.7%What's Next? - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Nasdaq 100 Index Life Science Scope - Kalkine Media
Can Maravai LifeSciences Holdings Inc. (MAR) stock survive global slowdownEarnings Performance Report & Capital Efficient Trade Techniques - Улправда
Does Maravai LifeSciences Holdings Inc. stock trade at a discount to peersTrade Entry Report & AI Optimized Trade Strategies - Улправда
Shorts Report: How Maravai LifeSciences Holdings Inc. (MAR) stock gains from tech spendingJuly 2025 Chart Watch & Expert Approved Trade Ideas - Улправда
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
2025-12-18 | Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation | NDAQ:MRVI | Press Release - Stockhouse
Can Maravai LifeSciences Holdings Inc. stock attract ESG capital inflowsOil Prices & Free Verified High Yield Trade Plans - Улправда
Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) 29% Jump Shows Its Popularity With Investors - 富途牛牛
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect - ACCESS Newswire
Why Analysts See Maravai’s Story Shifting After Target Cut And Washed Out Share Price Range - Yahoo Finance
Wells Fargo maintains Maravai LifeSciences Holdings (MRVI) overweight recommendation - MSN
MRVI: Wells Fargo Maintains Rating and Raises Price Target | MRV - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2025 in Maravai LifeSciences LawsuitMRVI - ACCESS Newswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionMRVI - 28/22 News
Maravai LifeSciences Holdings, Inc. $MRVI Stock Holdings Boosted by Immersion Corp - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Up Following Insider Buying Activity - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Director Purchases $190,446.40 in Stock - MarketBeat
Maravai Lifesciences (MRVI) Director Acquires 100K Shares - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2025-12-09 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation | NDAQ:MRVI | Press Release - Stockhouse
마라바이 라이프 (MRVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):